A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)
Clinical trial NCT04965155 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04965155
- Sponsor
- EMN Trial Office S.r.l. Impresa Sociale
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-21
- Primary completion
- 2023-11-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.